Category:Daniel J. SIEGWART of Dallas TX (US)

Daniel J. SIEGWART of Dallas TX (US)

Executive Summary

Daniel J. SIEGWART of Dallas TX (US) is an inventor who has filed 10 patents. Their primary areas of innovation include PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (7 patents), Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (7 patents), ACYCLIC OR CARBOCYCLIC COMPOUNDS (6 patents), and they have worked with companies such as The Board of Regents of The University of Texas System (10 patents). Their most frequent collaborators include (6 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61K47/60 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 7 patents
• A61K48/0041 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 7 patents
• C07C321/14 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 6 patents
• A61K9/513 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 6 patents
• A61K9/5146 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 6 patents
• A61K31/7105 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 6 patents
• A61K31/7125 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 6 patents
• A61K47/20 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 6 patents
• A61K47/22 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 6 patents
• A61K47/59 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 6 patents
• A61K47/6931 (the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit): 6 patents
• C07C323/52 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 6 patents
• C07D295/15 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 6 patents
• C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 3 patents
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• A61K47/543 ({Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}): 2 patents
• A61K9/5123 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N15/88 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• A61K48/0033 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 2 patents
• C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids}): 2 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 2 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N2320/32 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• A61K47/593 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/542 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K48/005 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
• C12N15/102 ({Mutagenizing nucleic acids}): 1 patents
• C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C07C311/32 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
• A61K47/6911 ({the form being a liposome}): 1 patents
• B82Y5/00 (Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery): 1 patents
• C07C229/06 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
• C07C309/14 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
• C07F9/091 (ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins): 1 patents
• C07F9/106 (ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins): 1 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

List of Companies

• The Board of Regents of The University of Texas System: 10 patents

Collaborators

• Kejin ZHOU of Dallas TX (US) (6 collaborations)
• Sang M. LEE of Dallas TX (US) (1 collaborations)
• Lukas FARBIAK of Dallas TX (US) (1 collaborations)
• Jason B. MILLER of Dallas TX (US) (1 collaborations)
• Qiang CHENG of Dallas TX (US) (1 collaborations)
• Tuo WEI of Dallas TX (US) (1 collaborations)